Patent details

EP2234645 Title: PEG-INTERFERON-BETA FORMULATIONS

Basic Information

Publication number:
EP2234645
PCT Application Number:
PCT/EP/2008/067876
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP088638333
PCT Publication Number:
WO/2009/080699
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PEG-INTERFERON-BETA FORMULATIONS
French Title of Invention:
FORMULATIONS DE PEG-INTERFÉRON-BÊTA
German Title of Invention:
PEG-INTERFERON-BETA-FORMULIERUNGEN
SPC Number:

Dates

Filing date:
18/12/2008
Grant date:
02/05/2012
EP Publication Date:
02/05/2012
PCT Publication Date:
02/07/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/10/2010
EP B1 Publication Date:
02/05/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
18/12/2016
Expiration date:
18/12/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/12/2008
 
 

Name:
Merck Serono S.A.
Address:
Centre Industriel, 1267 Coinsins, Switzerland (CH)

Inventor

1

Name:
DEL RIO Alessandra
Address:
Italy (IT)

2

Name:
RICHARD Joel
Address:
France (FR)

Priority

1

Priority Number:
07150258
Priority Date:
20/12/2007
Priority Country:
European Patent Office (EPO) (EP)

2

Priority Number:
10258
Priority Date:
07/01/2008
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 47/48;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
08/12/2015
Last Annual Fee Paid Number:
8
Last Annual Fee Paid Amount:
99 Euro
Payer:
MARKS & CLERK LLP
Filing date Document type Number of pages